search again

Tocilizumab Infusion for COVID-19, First Dose

Nationwide rates for HCPCS M0249

Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, first dose

Rates data updated July 2026.

Facilitymedian $447 · 10th–90th $437$1,6600%50%10th90th$447Professionalmedian $447 · 10th–90th $447$6460%50%90th$447$5.0$50.0$500.0$5.0K$50.0K$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
Aetna
Setting
Professional
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$446.68
BCBS
Setting
Facility
Modifier
Global
Typical Low
$446.68
Median
$1,230.27
Typical High
$33,113.11
BCBS
Setting
Professional
Modifier
Global
Typical Low
$100.00
Median
$446.68
Typical High
$549.54
Cigna
Setting
Facility
Modifier
Global
Typical Low
$446.68
Median
$446.68
Typical High
$562.34
Cigna
Setting
Professional
Modifier
Global
Typical Low
$398.11
Median
$446.68
Typical High
$562.34
United
Setting
Facility
Modifier
Global
Typical Low
$426.58
Median
$537.03
Typical High
$1,479.11
United
Setting
Professional
Modifier
Global
Typical Low
$416.87
Median
$588.84
Typical High
$1,096.48